CCL2–CCR2 and CXCL1–CXCR2 pathways, well-described pro-angiogenic chemokines, mediate corneal neovascularization, hepatic angiogenesis, endothelial recovery in arterial injury, and cancer-related angiogenesis31–36. The gene discussed is CXCL1; the disease is cancer.